Your browser doesn't support javascript.
loading
Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers.
Mc Leer, Anne; Foll, Matthieu; Brevet, Marie; Antoine, Martine; Novello, Silvia; Mondet, Julie; Cadranel, Jacques; Girard, Nicolas; Giaj Levra, Matteo; Demontrond, Pierre; Audigier-Valette, Clarisse; Letouzé, Eric; Lantuéjoul, Sylvie; Fernandez-Cuesta, Lynnette; Moro-Sibilot, Denis.
Affiliation
  • Mc Leer A; Université Grenoble Alpes, Grenoble, France; Service d'Anatomie et Cytologie Pathologiques, Pôle de Biologie et Pathologie, CHU Grenoble Alpes, Grenoble, France; UGA/INSERM U1209/CNRS 5309-Institute for Advanced Biosciences - Université Grenoble Alpes, Grenoble, France. Electronic address: amcleer@c
  • Foll M; International Agency for Research on Cancer (IARC-WHO), Section of Genetics, Lyon, France.
  • Brevet M; Hospices Civils de Lyon, Institut de pathologie Multisite, Site Est, Bron and Université Claude Bernard Lyon 1, Lyon, France.
  • Antoine M; Service d'Anatomie et Cytologie Pathologique, APHP, Hôpital Tenon, 75020 Paris, France and Theranoscan CRC#4 and Curamus Sorbonne Université, Paris, France.
  • Novello S; Department of Oncology, AOU San Luigi-Orbassano, University of Turin, Italy.
  • Mondet J; Université Grenoble Alpes, Grenoble, France; Service d'Anatomie et Cytologie Pathologiques, Pôle de Biologie et Pathologie, CHU Grenoble Alpes, Grenoble, France; UGA/INSERM U1209/CNRS 5309-Institute for Advanced Biosciences - Université Grenoble Alpes, Grenoble, France.
  • Cadranel J; Service de Pneumologie et Oncologie thoracique, APHP, Hôpital Tenon and GRC#4 Theranoscan and Curamus Sorbonne Université, Paris, France.
  • Girard N; Institut Curie, Paris, France.
  • Giaj Levra M; Clinique Hospitalo-Universitaire de Pneumologie Physiologie, Pôle Thorax et Vaisseaux, CHU Grenoble Alpes, Grenoble, France.
  • Demontrond P; Centre François Baclesse, Caen, France.
  • Audigier-Valette C; Department of Pulmonary Diseases, Centre Hospitalier Toulon Sainte-Musse, Toulon, France.
  • Letouzé E; Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Université de Paris, Université Paris Nord, Functional Genomics of Solid Tumors Laboratory, Equipe Labellisée Ligue Contre le Cancer, F-75006 Paris, France.
  • Lantuéjoul S; Université Grenoble Alpes, Grenoble, France; Cancer Research Center Lyon, Centre Léon Bérard, Lyon, France.
  • Fernandez-Cuesta L; International Agency for Research on Cancer (IARC-WHO), Section of Genetics, Lyon, France.
  • Moro-Sibilot D; Université Grenoble Alpes, Grenoble, France; UGA/INSERM U1209/CNRS 5309-Institute for Advanced Biosciences - Université Grenoble Alpes, Grenoble, France; Clinique Hospitalo-Universitaire de Pneumologie Physiologie, Pôle Thorax et Vaisseaux, CHU Grenoble Alpes, Grenoble, France.
Lung Cancer ; 167: 98-106, 2022 05.
Article in En | MEDLINE | ID: mdl-35183375
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Small Cell / Telomerase / Small Cell Lung Carcinoma / Adenocarcinoma of Lung / Lung Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Small Cell / Telomerase / Small Cell Lung Carcinoma / Adenocarcinoma of Lung / Lung Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2022 Type: Article